Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Platelet storage and transfusions: new concerns associated with an old therapy.

Sahler J, Grimshaw K, Spinelli SL, Refaai MA, Phipps RP, Blumberg N.

Drug Discov Today Dis Mech. 2011 Summer;8(1-2):e9-e14. Epub 2011 Jul 20.

2.

Platelet Transfusion and Thrombosis: More Questions than Answers.

Schmidt AE, Refaai MA, Blumberg N.

Semin Thromb Hemost. 2016 Mar;42(2):118-24. doi: 10.1055/s-0035-1564833. Epub 2015 Dec 30. Review.

PMID:
26716501
3.

Pathogen-reduced platelets for the prevention of bleeding.

Butler C, Doree C, Estcourt LJ, Trivella M, Hopewell S, Brunskill SJ, Stanworth S, Murphy MF.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD009072. doi: 10.1002/14651858.CD009072.pub2. Review.

PMID:
23543569
4.

The relationship between the duration of platelet storage and the development of transfusion reactions.

Sarkodee-Adoo CB, Kendall JM, Sridhara R, Lee EJ, Schiffer CA.

Transfusion. 1998 Mar;38(3):229-35.

PMID:
9563401
5.

New strategies for the optimal use of platelet transfusions.

Blajchman MA, Slichter SJ, Heddle NM, Murphy MF.

Hematology Am Soc Hematol Educ Program. 2008:198-204. doi: 10.1182/asheducation-2008.1.198.

PMID:
19074082
6.

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.

Stanworth SJ, Hyde C, Heddle N, Rebulla P, Brunskill S, Murphy MF.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004269. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD004269.

PMID:
15495093
7.

Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats.

Abrams-Ogg AC.

Vet Clin North Am Small Anim Pract. 2003 Nov;33(6):1401-18. Review.

PMID:
14664205
8.

Optimal dosing and triggers for prophylactic use of platelet transfusions.

Rinder HM, Arbini AA, Snyder EL.

Curr Opin Hematol. 1999 Nov;6(6):437-41. Review.

PMID:
10546800
9.

Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.

de Wildt-Eggen J, Nauta S, Schrijver JG, van Marwijk Kooy M, Bins M, van Prooijen HC.

Transfusion. 2000 Apr;40(4):398-403.

PMID:
10773049
10.

Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.

Hux BD, Martin LG.

J Vet Emerg Crit Care (San Antonio). 2012 Feb;22(1):73-80. doi: 10.1111/j.1476-4431.2011.00706.x. Review.

PMID:
23016744
12.

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.

Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH.

Arch Intern Med. 2008 Nov 24;168(21):2377-81. doi: 10.1001/archinte.168.21.2377.

13.

Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes.

Refaai MA, Phipps RP, Spinelli SL, Blumberg N.

Thromb Res. 2011 Apr;127(4):287-91. doi: 10.1016/j.thromres.2010.10.012. Epub 2010 Nov 19. Review.

14.

Platelet transfusions: the science behind safety, risks and appropriate applications.

Spiess BD.

Best Pract Res Clin Anaesthesiol. 2010 Mar;24(1):65-83. Review.

PMID:
20402171
15.

Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.

Vadhan-Raj S, Kavanagh JJ, Freedman RS, Folloder J, Currie LM, Bueso-Ramos C, Verschraegen CF, Narvios AB, Connor J, Hoots WK, Broemeling LD, Lichtiger B.

Lancet. 2002 Jun 22;359(9324):2145-52.

PMID:
12090979
16.

Bacterial contamination of platelet concentrates: incidence, significance, and prevention.

Blajchman MA, Goldman M.

Semin Hematol. 2001 Oct;38(4 Suppl 11):20-6. Review.

PMID:
11727282
17.

Novel platelet storage conditions: additive solutions, gas, and cold.

Capocelli KE, Dumont LJ.

Curr Opin Hematol. 2014 Nov;21(6):491-6. doi: 10.1097/MOH.0000000000000081. Review.

PMID:
25144411
18.

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.

Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy MF, Tinmouth A, Heddle N.

Cochrane Database Syst Rev. 2012 May 16;(5):CD004269. doi: 10.1002/14651858.CD004269.pub3. Review.

PMID:
22592695
19.

Platelet transfusions for patients with haematological malignancies: who needs them?

Estcourt LJ, Stanworth SJ, Murphy MF.

Br J Haematol. 2011 Aug;154(4):425-40. doi: 10.1111/j.1365-2141.2010.08483.x. Epub 2011 May 25. Review.

PMID:
21615375

Supplemental Content

Support Center